Dopamine agonists tied to higher risk for psychiatric events
(HealthDay)—Patients with primary restless leg syndrome who begin dopamine agonist (DA) therapy may be at increased risk for adverse psychiatric events, according to a study published in the September issue of the Journal ...
Oct 17, 2019
0
2